{"Symbol": "LLY", "AssetType": "Common Stock", "Name": "Eli Lilly and Company", "Description": "Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.", "CIK": "59478", "Exchange": "NYSE", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "DRUG MANUFACTURERS - GENERAL", "Address": "LILLY CORPORATE CENTER, INDIANAPOLIS, IN, UNITED STATES, 46285", "OfficialSite": "https://www.lilly.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-12-31", "MarketCapitalization": "932315070000", "EBITDA": "31693001000", "PERatio": "45.26", "PEGRatio": "0.889", "BookValue": "29.66", "DividendPerShare": "6", "DividendYield": "0.0058", "EPS": "22.98", "RevenuePerShareTTM": "72.64", "ProfitMargin": "0.317", "OperatingMarginTTM": "0.449", "ReturnOnAssetsTTM": "0.194", "ReturnOnEquityTTM": "1.012", "RevenueTTM": "65179001000", "GrossProfitTTM": "54127002000", "DilutedEPSTTM": "22.98", "QuarterlyEarningsGrowthYOY": "0.514", "QuarterlyRevenueGrowthYOY": "0.426", "AnalystTargetPrice": "1201.63", "AnalystRatingStrongBuy": "4", "AnalystRatingBuy": "17", "AnalystRatingHold": "7", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "1", "TrailingPE": "45.26", "ForwardPE": "30.86", "PriceToSalesRatioTTM": "14.3", "PriceToBookRatio": "35.08", "EVToRevenue": "15.59", "EVToEBITDA": "32.07", "Beta": "0.394", "52WeekHigh": "1132.06", "52WeekLow": "620.46", "50DayMovingAverage": "1049.85", "200DayMovingAverage": "863.63", "SharesOutstanding": "895019000", "SharesFloat": "890963000", "PercentInsiders": "0.176", "PercentInstitutions": "84.568", "DividendDate": "2026-03-10", "ExDividendDate": "2026-02-13"}